warfarin and Carcinoma-256--Walker

warfarin has been researched along with Carcinoma-256--Walker* in 6 studies

Trials

1 trial(s) available for warfarin and Carcinoma-256--Walker

Article	Year
The rationale of anticoagulants in the treatment of cancer. Journal of medicine, 1974, Volume: 5, Issue:1 Topics: Animals; Anticoagulants; Blood Coagulation; Carcinoma 256, Walker; Cecal Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fibrinolysin; Fibrinolytic Agents; Heparin; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Ovarian Neoplasms; Pelvic Neoplasms; Rabbits; Stomach Neoplasms; Swine; Thrombosis; Vena Cava, Superior; Warfarin	1974

Article

Year

The rationale of anticoagulants in the treatment of cancer.

Journal of medicine, 1974, Volume: 5, Issue:1

Topics: Animals; Anticoagulants; Blood Coagulation; Carcinoma 256, Walker; Cecal Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fibrinolysin; Fibrinolytic Agents; Heparin; Humans; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Ovarian Neoplasms; Pelvic Neoplasms; Rabbits; Stomach Neoplasms; Swine; Thrombosis; Vena Cava, Superior; Warfarin

1974

Other Studies

5 other study(ies) available for warfarin and Carcinoma-256--Walker

Article	Year
Hypersensitivity to warfarin in rats with Walker 256 carcinoma. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1982, Volume: 169, Issue:1 Topics: Animals; Blood Coagulation; Blood Coagulation Factors; Carcinoma 256, Walker; Drug Tolerance; Factor VII; Factor X; Male; Prothrombin; Rats; Rats, Inbred Strains; Turpentine; Vitamin K; Warfarin	1982
Anticoagulant treatment of rats with Walker 256 carcinosarcoma. Journal of cancer research and clinical oncology, 1982, Volume: 104, Issue:1-2 Various anticoagulant, antiplatelet, and fibrinolytic agents have been found to be effective in reducing metastatic growth of experimental animal tumors. This effectiveness is attributed to the requirement for hemostatic factors in the implantation and growth of metastases. However, clotting and platelet factors are also present at the site of a primary tumor, the Walker 256 carcinosarcoma. Yet maximally tolerated doses of heparin or warfarin did not affect the primary growth of this rat tumor. Topics: Animals; Anticoagulants; Carcinoma 256, Walker; Heparin; Rats; Rats, Inbred Strains; Warfarin	1982
In vitro effect of sodium warfarin on DNA and RNA synthesis of mouse L1210 leukemic cells and Walker tumor cells. Oncology, 1973, Volume: 28, Issue:3 Topics: Animals; Carcinoma 256, Walker; Cells, Cultured; DNA, Neoplasm; Leukemia L1210; Mice; Rats; RNA, Neoplasm; Thymidine; Uridine; Warfarin	1973
[Long-term effect of coumadin on tumor takes of the Walker 256 carcinosarcoma]. Ospedali d'Italia - chirurgia, 1969, Volume: 20, Issue:3 Topics: Animals; Carcinoma 256, Walker; Female; Neoplasm Transplantation; Prothrombin Time; Rats; Warfarin	1969
Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat. Cancer, 1966, Volume: 19, Issue:2 Topics: Animals; Carcinoma 256, Walker; Lung Neoplasms; Neoplasm Metastasis; Rats; Warfarin	1966